Cargando…
IL-32γ potentiates tumor immunity in melanoma
Myeloid cells orchestrate the antitumor immune response and influence the efficacy of immune checkpoint blockade (ICB) therapies. We and others have previously shown that IL-32 mediates DC differentiation and macrophage activation. Here, we demonstrate that IL-32 expression in human melanoma positiv...
Autores principales: | Gruber, Thomas, Kremenovic, Mirela, Sadozai, Hassan, Rombini, Nives, Baeriswyl, Lukas, Maibach, Fabienne, Modlin, Robert L., Gilliet, Michel, von Werdt, Diego, Hunger, Robert E., Seyed Jafari, S. Morteza, Parisi, Giulia, Abril-Rodriguez, Gabriel, Ribas, Antoni, Schenk, Mirjam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7526542/ https://www.ncbi.nlm.nih.gov/pubmed/32841222 http://dx.doi.org/10.1172/jci.insight.138772 |
Ejemplares similares
-
Tumor-Infiltrating Lymphocytes and Their Prognostic Value in Cutaneous Melanoma
por: Maibach, Fabienne, et al.
Publicado: (2020) -
Characterization of a Myeloid Activation Signature That Correlates with Survival in Melanoma Patients
por: Kremenovic, Mirela, et al.
Publicado: (2020) -
Recent Successes and Future Directions in Immunotherapy of Cutaneous Melanoma
por: Sadozai, Hassan, et al.
Publicado: (2017) -
Cannabinoid Receptor Type-2 in B Cells Is Associated with Tumor Immunity in Melanoma
por: Gruber, Thomas, et al.
Publicado: (2021) -
BCG hydrogel promotes CTSS-mediated antigen processing and presentation, thereby suppressing metastasis and prolonging survival in melanoma
por: Kremenovic, Mirela, et al.
Publicado: (2022)